News | Breast Density | February 14, 2019

Teleradiology provider will be first U.S. beta user for new densitasquality solution to enhance communication and compliance with FDA EQUIP mammography inspection program

Densitas Enters Partnership Agreement With TeleMammography Specialists

February 14, 2019 — Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography Specialists of Decatur, Ga. TeleMammography Specialists will be the first U.S. beta user for the new densitasquality solution from Densitas, which will be used to improve the communications and information sharing needed to meet EQUIP (Enhancing Quality Using the Inspection Program) guidelines. TeleMammography Specialists will also implement the recently released densitasdensity automated breast density assessment software.

Densitas will highlight the benefits and capabilities of both products at the 2019 Healthcare Information and Management Systems Society (HIMSS) annual meeting, Feb. 11-15 in Orlando, Fla.

TeleMammography Specialists LLC. is an international teleradiology services provider that is specialized in breast imaging. Densitas Quality will help:

  • Streamline efforts to meet the U.S. Food and Drug Administration’s (FDA) EQUIP guidelines and prepare for mammography inspections;
  • Enable real-time feedback from the interpreting physicians to the technologists;
  • Automate EQUIP audit documentation requirements of the lead interpreting physician/auditing physician;
  • Simplify the ability to meet the proactive quality control requirements of EQUIP; and
  • Identify technologist performance issues quickly and accurately to facilitate ongoing training and communication that improves image and service quality.

By making densitasquality and densitasdensity available to all of TeleMammography Specialists clients, over 60,000 women will benefit annually. "Densitas will help us provide consistent quality and standardize density assessment among our radiologists", said Martha H. Garrison, M.D., president and CEO of TeleMammography Specialists, LLC. "We will be able to more proactively manage the needs of our clients and provide consistently high quality of care."

The artificial intelligence (AI)-powered densitasdensity software delivers fully automated, standardized and reliably reproducible breast density assessment. Additionally, densitasdensity results can be incorporated in risk models to generate standardized and reliably reproducible breast cancer risk assessment.

For more information: www.densitas.health


Related Content

Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
Subscribe Now